Fund
Grove Ventures
Grove Ventures led the round of Scala Biodesign (16 M$, Series A) on 9 April 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 1
- New entries
- 0
- Follow ons
- 0
- Latest operation
- 9 April 2026
- Sectors
- Health software
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 09 Apr | Israel, Health software | Series A | 16 M$ | Lead |
Co investors 2 funds crossed
Funds that appeared in the same rounds, in any capacity. Geographies logged: Israel.